Mohamed, A., Bennett, N., Ploetz, J., Aragon, L., Kennedy, K., & Boyd, S. E. (2020). 266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia. Open Forum Infect Dis.
Chicago Style aipamenaMohamed, Adham, Nick Bennett, Jeannette Ploetz, Laura Aragon, Kevin Kennedy, and Sarah E. Boyd. "266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus Aureus Bacteremia." Open Forum Infect Dis 2020.
MLA aipamenaMohamed, Adham, et al. "266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus Aureus Bacteremia." Open Forum Infect Dis 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.